HIV and the lung

Current Opinion in Pulmonary Medicine

Volumn 4, Issue 3, 1998, Pages 135-141

  Wallace, Jeanne Marie ^a  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIDS RELATED COMPLEX; BACTERIAL PNEUMONIA; BRONCHITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INCIDENCE; LUNG; PATHOLOGY; PNEUMOCYSTIS PNEUMONIA; PROGNOSIS; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; VIRUS PNEUMONIA;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRONCHITIS; HIV INFECTIONS; HUMANS; INCIDENCE; LUNG; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCYSTIS; PNEUMONIA, VIRAL; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 0032060559     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report 1997, 9:1-37.
2. Gulik RM, Mellors JW, Havlir D, et al.: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Eng J Med 1997, 337:734-739.
3. Hammer SM, Squires KE, Hughes MD, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cells counts of 200 per cubic millimeter or less. N Eng J Med 1997, 337:725-733.
4. Wallace JM, Hansen NI, LaVange L, Glassroth J, Browdy BL, Rosen MJ, Kvale PA, Mangura BT, Reichman LB, Hopewell PC, and the Pulmonary Complications of HIV Infection Study Group: Respiratory disease trends in the pulmonary complications of HIV Infection Study Cohort. Am J Respir Crit Care Med 1997, 155:72-80. A report of respiratory disease trends over a 5-year period in a large multicenter cohort of persons having three major HIV risk factors and all stages of HIV disease.
5. Wallace JM, Au J, Richer B, Sayre J, Ziment I: Empiric treatment of presumed P. carinii pneumonia (PCP) in HIV disease: a decision analysis. Am J Respir Crit Care Med 1997, 155(suppl):A229.
6. McGuinness G: Changing trends in the pulmonary manifestations of AIDS. Radiol Clin North Am 1997, 35:1029-1082. Describes newly recognized features of established HIV-related pulmonary disorders as well as recently recognized diseases with CT images.
7. Agostini C, Semenzato G: Immunologic effects of HIV in the lung. Clin Chest Med 1996, 17:633-646. An excellent summary of current understanding of pulmonary cellular and immune processes in HIV disease.
8. Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M: Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 1997, 155:996-1003.
9. Lipman MCI, Johnson MA, Poulter LW: Functionally relevant changes occur in HIV-infected individuals' alveolar macrophages prior to the onset of respiratory disease. AIDS 1997, 11:765-772.
10. Stansell JD, Osmond DH, Charlebois E, LaVange L, Wallace JM, Alexander BV, Glassroth J, Kvale PA, Rosen MJ, Reichman LB, Turner J, Hopewell, and the Pulmonary Complications of HIV Infection Study Group: Predictors of Pneumocystis carinii pneumonia in HIV-Infected persons. Am J Respir Crit Care Med 1997, 155:60-66.
11. Veenstra J, Veugelers PJ, Kreet IPM, VanderVen AJAM, Miedema F, Lange JMA, Coutinho RA: Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis. Clin Infec Dis 1997, 24:936-941.
12. Boiselle PM, Tocino I, Hooley RJ, Pumerantz AS, Selwyn PA, Neklesa VP, Lange RC: Chest radiograph interpretation of Pneumocystis carinii pneumonia, bacterial pneumonia, and pulmonary tuberculosis in HIV-positive patients: accuracy, distinguishing features, and mimics. J Thoracic Imaging 1997, 12:47-53.
13. Amin Z, Miller RF, Shaw PJ: Lobar or segmental consolidation on chest radiographs of patients with HIV infection. Clinical Radiology 1997, 52:541-545.
14. Gruden JF, Huang L, Turner J, Webb WR, Merrifield C, Stansell JD, Gamsu G, Hopewell PC: High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings. AJR Am J Roentgenol 1997, 169:967-975. High-resolution CT in patients with normal, equivocal, or nonspecific chest radiographic findings clinically suspected to have PCP can exclude or predict PCP with a high degree of accuracy, thus potentially avoiding the need for invasive procedures in some situations.
15. Boldt MJ, Bai TR: Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia. Chest 1997, 111:1187-1192.
16. DeGracia J, Miravitlles M, Mayordomo C, Ferrer A, Alvarez A, Bravo C, Vendrell M: Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients. Chest 1997, 111:1180-1186.
17. O'Brien JG, Dong BJ, Coleman RL, Gee L, Balano KB: A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia. Clin Infec Dis 1997, 24:854-859.
18. Benfield TL, Prento P, Junge J, Vestbo J, Lundgren JD: Alveolar damage in AIDS-related Pneumocystis carinii pneumonia. Chest 1997, 111:1193-1199.
19. Sharma R, Herndon B, Dew M, Rosa U: Survival benefits of pulmonary cellular activation in AIDS patients with Pneumocystis infection. South Med J 1997, 90:531-534.
20. Salomon N, Gomez T, Perlman DC, Laya L, Eber C, Mildvan D: Clinical features and outcome of HIV-related cytomegalovirus pneumonia. AIDS 1997, 11:319-324. A relatively large series of patients with HIV disease and biopsy proven cytomegalovirus pneumonia without evidence of additional pathogens.
21. Waxman AB, Goldie SJ, Brett-Smith H, Matthay RA: Cytomegalovirus as a primary pulmonary pathogen in AIDS. Chest 1997, 111:128-134.
22. Hansen KK, Vestbo J, Benfield T, Lundgren JD, Mathiesen LR: Rapid detection of cytomegalovirus in bronchoalveolar lavage fluid and serum samples by polymerase chain reaction: correlation of virus isolation and clinical outcome for patients with human immunodeficiency virus infection. Clin Infec Dis 1997, 24:878-883.
23. Markowitz N, Hansen NI, Hopewell PC, Glassrith J, Kavale PA, Mangura BT, Wilcosky TC, Wallace JM, Rosen MJ, Reichman LB, and the Pulmonary Complication of HIV Infection Study Group: Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med 1997, 126:123-132.
24. Moreno S, Miralles P, Diaz MD, Baraia J, Padilla B, Berenguer J, Alberdi JC: Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Arch Intern Med 1997, 157:1729-1734.
25. Gordin FM, Matts JP, Miller C, Brown LS, Hafner R, John SL, Klein M, Vaughn A, Besch CL, Perez G, Szabo S, El-Sadr W: A controlled trial of isoniazid in persons with energy and human immunodeficiency virus infection who at high risk for tuberculosis. N Engl J Med 1997, 337:315-320. Recommends no isoniazid prophylaxis in high-risk patients with HIV disease and anergy unless they have been exposed to active tuberculosis based on the results of multicenter, randomized, double-blinded, placebo-controlled trial.
26. Haramati LB, Jenny-Avital ER, Alterman DD: Effect of HIV status on chest radiographic and CT findings in patients with tuberculosis. Clin Radiol 1009, 52:31-35.
27. Alpert PL, Musiff SS, Gourevitch MN, Greenberg B, Klein RS: A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis 1997, 24:661-668.
28. Jones BE, Oo MM, Taikwel EK, Qian D, Kumar A, Maslow ER, Barnes PF: CD4 cell counts in human deficiency virus-negative patients with tuberculosis. Clin Infect Dis 1997, 24:988-991.
29. Finch D, Beaty CD: The utility of a single sputum specimen in the diagnosis of tuberculosis: comparison between HIV-infected and non-HIV infected patients. Chest 1997, 111:1174-1179.
30. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J: Site of infection and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS 1997, 11:455-460.
31. Laissy J-P, Cadi M, Cinqualbre A, Boudiaf ZE, Lariven S, Casalino E, Wolff M, Schouman-Claeys E: Mycobacterium tuberculosis versus nontuberculous mycobacterial infection of the lung in AIDS patients: CT and HRCT patterns. J Comput Assist Tomogr 1997, 21:312-317.
32. Campo RE, Canipo CE: Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997, 24:1233-1238. The experience with a relatively large series of patients with HIV disease and M. kansasii infection.
33. Fishman JE, Schwanz DS, Sais GJ: Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of radiographic findings. Radiology 1997, 204:171-175.
34. Jiva TM, Jacoby H, Weymouth LA, Kaminski DA, Portmore AC: Mycobacterium xenopi: innocent bystander or emerging pathogen? Clin Infect Dis 1997, 24:226-232.
35. Piersimoni C, Tortoli E, deLalla F, Nista D, Donato D, Bornigia S, DeSio G: Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus. Clin Infect Dis 1997, 24:144-147.
36. Rabaud D, May T, Lucet JC, Leport C, Ambroise-Thomas P, Canton P: Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: a French national survey. Clin Infect Dis 1997, 23:1249-1254.
37. McKinsey DS, Spiegel RA, Hutwagner L, Standford J, Driks MR, Brewer J, Gupta MR, Smith DL, O'Connor MC, Dall L: Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 1997, 24:1195-1203. A well designed prospective study of the risk factors and course of histoplasmosis in an endemic area.
38. Corcoran GR, Al-Abdely H, Flanders CD, Geimer J, Patterson TF: Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 1997, 24:942-944.
39. Shetty D, Giri N, Gonzalez CE, Pizzo PA, Walsh TJ: Invasive aspergillosis in human immunodeficiency virus-infected children. Pedatr Infect Dis J 1997, 16:216-221.
40. Addrizzo-Harris DJ, Harken TJ, McGuinness G, Naidich DP, Rom WN: Pulmonary aspergilloma and AIDS: a comparison of HIV-infected and HIV-negative individuals. Chest 1997, 111:612-618.
41. Gori S, Lupetti A, Moscato G, Parenti M, Lofaro A: Pulmonary sporotrichosis with hyphae in a human immunodeficiency virus-infected patient: a case report. Acta Cytol 1997, 41:519-521.
42. Miller KD, Mican JM, Davey RT: Asymptomatic solitary pulmonary nodules due to Cryptococcus neoformans in patients infected with human immunodeficiency virus. Clin Infect Dis 1996, 23:810-812.
43. Martinez-Marcos FJ, Viciana P, Canas E, Martin-Juan J, Moreno I, Pachon J: Etiology of solitary pulmonary nodules in patients with human immunodeficiency virus infection. Clin Infect Dis 1997, 24:908-913.
44. Wallace JM, Stone GS, Browdy BL, Tashtan DP, Hopewell PC, Glassroth J, Rosen MJ, Reichman LB, Kvale PA, and the Pulmonary Complications of HIV Infection Study Group: Nonspecific airway hyperresponsiveness in HIV disease. Chest 1997, 111:121-127.
45. McGuinness G, Gruden JF, Bhalla M, Harkin TJ, Jagirdar JS, Naidich: AIDS-related airway disease. AJR Am J Roentgenol 1997, 168:67-77. A review of HIV-related airway abnormalities for which CT imaging is an accurate means of diagnosis.
46. King MA, Neal DE, St. John R, Tsai J, Diaz PT: Bronchial dilatation in patients with HIV infections: CT assessment and correlation with pulmonary function test and findings at bronchoalveolar lavage. AJR Am J Roentgenol 1997, 168:1535-1540.
47. Opravil M, Pechere M, Speich R, Joller-Jemelka HI, Jenni R, Russi EW, Hirschel B, Luthy R and the Swiss HIV Cohort Study. HIV-associated primary pulmonary hypertension: A case control study. Am J Respir Crit Care Med 1997, 155:990-995. Reports the findings of a study that examined the course, prognosis, and possible etiology of primary pulmonary hypertension as a rare complication of HIV disease.
48. Cool CD, Kennedy D, Voelkel NF, Tuder RM: Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 1997, 28:434-442.
49. Johnson CC, Wilcosky T, Kvale PA, Rosen M, Stansell J, Glassroth J, Reichman L, Wallace J, Markowitz N, Thompson JE, Hopewell P, and the Pulmonary Complications of HIV Infection Study Group: Cancer incidence among an HIV-infected cohort. Am J Epidemiol 1997, 146:470-475.